Recently, Fuji announced a medium-term management plan called vision 2023. It is obvious from the plan that Fuji will shift its focus to the medical business, while the imaging business is only mentioned at the end of the press release. Compared with “we strive to occupy the first market share in the high-end anti counterfeiting market” in 2019, it has obvious changes. The camera market has been going downhill in the past two years, but Fuji’s market strategy of Chinese frame with APS-C frame is still very good. I believe Fuji will stick to the image field and will not give up easily! What do you think?
Via: camera beta
Author: Shen Pei